Article
Identification of circulating protein biomarkers for pancreatic cancer cachexia
2018-06-30
Abstract excerpt
<h4>Background</h4> Over 80% of patients with pancreatic ductal adenocarcinoma (PDAC) suffer from cachexia, characterized by severe muscle and fat loss. Although various model systems have improved our understanding of cachexia, translating the findings to human cachexia has remained a challenge. In this study, our objectives were to i) identify circulating protein biomarkers using serum for human PDAC cachexia,...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 56a45f50-7f32-5eab-84d9-5e3424cfd13a
- DOI
- 10.1101/359661